# China NMPA Drug Inspection - Jinshaotang Chinese Herbal Pieces Co., Ltd. - Chinese herbal medicine slices

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jinshaotang-chinese-herbal-pieces-co-ltd/8ebccff8-749e-462f-98a9-56aaad5a6c2d/
Source feed: China

> China NMPA drug inspection for Jinshaotang Chinese Herbal Pieces Co., Ltd. published November 18, 2019. Drug: Chinese herbal medicine slices. The Shandong Provincial Food and Drug Administration (Shandong FDA) issued an announcement on May 7, 2018, detailing sig

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Shandong Provincial Food and Drug Administration Regarding 72 Batches of Drugs Failing Quality Inspection
- Company Name: Jinshaotang Chinese Herbal Pieces Co., Ltd.
- Publication Date: 2019-11-18
- Drug Name: Chinese herbal medicine slices
- Inspection Finding: The quality does not meet the standard requirements.
- Action Taken: Control measures such as sealing, seizure, suspension of sales, and product recall were implemented, and cases were filed against the relevant manufacturers and sampled units in accordance with relevant laws and regulations.
- Summary: The Shandong Provincial Food and Drug Administration (Shandong FDA) issued an announcement on May 7, 2018, detailing significant quality deficiencies found in 72 batches of drugs. Inspections, conducted by 14 drug testing institutions, revealed two batches of finished drugs from two companies, including Hebei Kainuo Pharmaceutical Co., Ltd., and 70 batches of traditional Chinese medicine (TCM) slices from 47 companies, including Jinshaotang Traditional Chinese Medicine Slices Co., Ltd., to be substandard. The exact nature of these quality failures was not specified, but they represent a clear non-compliance with pharmaceutical quality standards. Operating within China's National Medical Products Administration (NMPA) regulatory framework, the Shandong FDA initiated stringent control measures. These actions included sealing, seizing, and suspending sales of the affected products, alongside mandatory recalls. Furthermore, legal proceedings have been launched against the responsible manufacturers and sampled units. The announcement emphasizes the need for intensified supervision by municipal food and drug administrations, urging companies to investigate the root causes of these issues, implement comprehensive rectification measures, and effectively eliminate potential public health risks.

Company: https://www.globalkeysolutions.net/companies/jinshaotang-chinese-herbal-pieces-co-ltd/23ff4da5-fb07-4879-9402-eab281cb9e94/